Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy.
Huang K, Sun H, Chen Z, Li X, Wang S, Zhao X, Tang F, Jia Y, Hu T, Du X, Wang H, Lu Z, Huang J, Gui J, Wang X, Zhou S, Wang L, Zhang J, Guo L, Yang R, Shen J, Zhang Q, Li S, Wang S.
Huang K, et al. Among authors: zhao x.
Sci Rep. 2016 Jun 21;6:28278. doi: 10.1038/srep28278.
Sci Rep. 2016.
PMID: 27325186
Free PMC article.